KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Shares Outstanding (Weighted Average) (2017 - 2025)

Twist Bioscience (TWST) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $56.8 million as the latest value for Q2 2023.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 7.07% to $56.8 million in Q2 2023 year-over-year; TTM through Jun 2023 was $56.8 million, a 7.07% increase, with the full-year FY2022 number at $53.9 million, up 11.68% from a year prior.
  • Shares Outstanding (Weighted Average) was $56.8 million for Q2 2023 at Twist Bioscience, roughly flat from $56.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $56.8 million in Q1 2023 to a low of $23.5 million in Q1 2019.
  • A 5-year average of $44.5 million and a median of $48.5 million in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Biggest YoY gain for Shares Outstanding (Weighted Average) was 983143.82% in 2019; the steepest drop was 99.05% in 2019.
  • Twist Bioscience's Shares Outstanding (Weighted Average) stood at $33.0 million in 2019, then surged by 39.5% to $46.0 million in 2020, then grew by 8.5% to $49.9 million in 2021, then increased by 13.09% to $56.4 million in 2022, then rose by 0.55% to $56.8 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Shares Outstanding (Weighted Average) are $56.8 million (Q2 2023), $56.8 million (Q1 2023), and $56.4 million (Q4 2022).